![Ashish Koshy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Ashish Koshy has worked as a Chief Executive Officer at G42 Healthcare since 2020.
Postes actifs de Ashish Koshy
Sociétés | Poste | Début |
---|---|---|
G42 Healthcare
![]() G42 Healthcare Information Technology ServicesTechnology Services Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022. | Directeur Général | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
G42 Healthcare
![]() G42 Healthcare Information Technology ServicesTechnology Services Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022. | Technology Services |